Pancreatic Cancer Research

ResearcherSalk Institute for Biological StudiesActive in the last 2 years

Yu Shi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6742-9598; OpenAlex author ID A5083370352. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
33
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 3 papers · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 6

  1. Clinical functional proteomics of intercellular signalling in pancreatic cancer. Co-author DOI 10.1038/s41586-024-08225-y↗
  2. Inhibiting stromal Class I HDACs curbs pancreatic cancer progression. Co-author DOI 10.1038/s41467-023-42178-6↗
  3. Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts. First author DOI 10.1016/j.addr.2021.02.012↗
  4. Author Correction: Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring. Co-author DOI 10.1038/s41586-021-04176-w↗
  5. An engineered ligand trap inhibits leukemia inhibitory factor as pancreatic cancer treatment strategy. Co-author DOI 10.1038/s42003-021-01928-2↗
  6. Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring. Co-author DOI 10.1038/s41586-019-1130-6↗

Closest collaborators

The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tony R. Hunter · 5 shared papers, 2019–2025 · strength 0.60
  2. Peiwu Huang · 3 shared papers, 2019–2025 · strength 0.34
  3. Ruijun Tian · 3 shared papers, 2019–2025 · strength 0.34
  4. Gaoyang Liang · 3 shared papers, 2019–2023 · strength 0.28
  5. Corina E. Antal · 3 shared papers, 2019–2023 · strength 0.28
  6. Ronald M. Evans · 3 shared papers, 2019–2023 · strength 0.28
  7. Daniel D. Von Hoff · 3 shared papers, 2019–2023 · strength 0.28
  8. Huiqin Liu · 1 shared paper, 2021 · strength 0.22
  9. Feng Qian · 1 shared paper, 2021 · strength 0.22
  10. Yehan Zhang · 1 shared paper, 2025 · strength 0.20
  11. Yunguang Li · 1 shared paper, 2025 · strength 0.20
  12. Min Wang · 1 shared paper, 2025 · strength 0.20
  13. Dong Gao · 1 shared paper, 2025 · strength 0.20
  14. Renyi Qin · 1 shared paper, 2025 · strength 0.20
  15. Timothy R. Donahue · 2 shared papers, 2019–2021 · strength 0.14
  16. Kathleen E. DelGiorno · 2 shared papers, 2019–2021 · strength 0.14
  17. Nikki K. Lytle · 2 shared papers, 2019–2021 · strength 0.14
  18. Geoffrey Myles Wahl · 2 shared papers, 2019–2021 · strength 0.14
  19. Maya Ridinger-Saison · 2 shared papers, 2019–2021 · strength 0.14
  20. Ruilian Xu · 2 shared papers, 2019–2021 · strength 0.14
  21. Carlos Roberto Becerra · 2 shared papers, 2019–2021 · strength 0.14
  22. Eric Andrew Collisson · 2 shared papers, 2019–2021 · strength 0.14
  23. Michael Anthony Hollingsworth · 2 shared papers, 2019–2021 · strength 0.14
  24. Paul M. Grandgenett · 2 shared papers, 2019–2021 · strength 0.14
  25. Andrew M. Lowy · 2 shared papers, 2019–2021 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.